Literature DB >> 27855534

Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions.

Maurizio Sessa1, Claudia Rossi2, Concetta Rafaniello1, Annamaria Mascolo1, Daniela Cimmaruta1, Cristina Scavone1, Sonia Fiorentino1, Enrico Grassi2, Alfonso Reginelli2, Antonio Rotondo2, Liberata Sportiello1.   

Abstract

OBJECTIVE: The current study aims to assess the preventability of the contrast media adverse drug reactions reported through the Campania spontaneous reporting system, identifying the possible limitations emerged in this type of evaluation.
METHOD: All the individual case safety reports validated by the Campania Pharmacovigilance Regional Centre from July 2012 to September 2015 were screened to select those that reported contrast media as suspected drug. Campania Preventability Assessment Committee, in collaboration with clinicians specialized in Radiology, assessed the preventability according to the P-Method, through a case-by-case approach.
RESULTS: From July 2012 to September 2015, 13798 cases were inserted by pharmacovigilance managers in the Italian Pharmacovigilance Network database (in the geographical contest of the Campania Region), of which 67 reported contrast media as suspected drug. Five preventable cases were found. The most reported causes for preventability were the inappropriate drug use for the case clinical conditions and the absence of the preventive measure administrated prior to the contrast media administration. Several limitations were found in the evaluation of the critical criteria for the preventability assessment.
CONCLUSIONS: Educational initiatives will be organized directly to the healthcare professionals involved in the contrast media administration, to promote an appropriate use of the contrast media.

Entities:  

Keywords:  Adverse events; Campania region; contrast media; preventability; spontaneous reporting system

Mesh:

Substances:

Year:  2016        PMID: 27855534     DOI: 10.1080/14740338.2016.1226280

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  11 in total

1.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

2.  Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study.

Authors:  Cristina Scavone; Liberata Sportiello; Maria G Sullo; Carmen Ferrajolo; Rosanna Ruggiero; Maurizio Sessa; Pasquale M Berrino; Gabriella di Mauro; Liberato Berrino; Francesco Rossi; Concetta Rafaniello; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2017-09-06       Impact factor: 5.810

3.  Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions.

Authors:  Maurizio Sessa; Liberata Sportiello; Annamaria Mascolo; Cristina Scavone; Silvia Gallipoli; Gabriella di Mauro; Daniela Cimmaruta; Concetta Rafaniello; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2017-05-26       Impact factor: 5.810

Review 4.  Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review.

Authors:  Maurizio Sessa; Claudia Rossi; Annamaria Mascolo; Cristina Scavone; Gabriella di Mauro; Roberto Grassi; Liberata Sportiello; Salvatore Cappabianca; Concetta Rafaniello
Journal:  Ther Clin Risk Manag       Date:  2017-10-24       Impact factor: 2.423

5.  Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy.

Authors:  Cristina Scavone; Concetta Rafaniello; Simona Brusco; Michele Bertini; Enrica Menditto; Valentina Orlando; Ugo Trama; Liberata Sportiello; Francesco Rossi; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

6.  Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors.

Authors:  Maurizio Sessa; Gabriella di Mauro; Annamaria Mascolo; Concetta Rafaniello; Liberata Sportiello; Cristina Scavone; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2018-06-12       Impact factor: 5.810

7.  Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System.

Authors:  Annamaria Mascolo; Rosanna Ruggiero; Maurizio Sessa; Cristina Scavone; Liberata Sportiello; Concetta Rafaniello; Francesco Rossi; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2019-04-30       Impact factor: 5.810

8.  Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.

Authors:  Maurizio Sessa; Annamaria Mascolo; Cristina Scavone; Ilaria Perone; Annalisa Di Giorgio; Michele Tari; Annamaria Fucile; Antonella De Angelis; Daniel Bech Rasmussen; Magnus Thorsten Jensen; Kristian Kragholm; Francesco Rossi; Annalisa Capuano; Liberata Sportiello
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

9.  Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy.

Authors:  Francesca Guerriero; Valentina Orlando; Valeria Marina Monetti; Francesca Maria Colaccio; Maurizio Sessa; Cristina Scavone; Annalisa Capuano; Enrica Menditto
Journal:  Ther Clin Risk Manag       Date:  2018-10-08       Impact factor: 2.423

10.  Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.

Authors:  Cristina Scavone; Maurizio Sessa; Emilio Clementi; Giovanni Corrao; Roberto Leone; Alessandro Mugelli; Francesco Rossi; Edoardo Spina; Annalisa Capuano
Journal:  BioDrugs       Date:  2018-12       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.